Question · Q4 2025
Sean Paul Adams asked for more color on the non-accruals, noting a heavy skew towards healthcare and pharma segments, and inquired about specific workout strategies for these long-standing positions.
Answer
Armen Panossian, CEO and CIO of OCSL, explained that the non-accruals in healthcare and pharma primarily consist of a few chunky, long-standing positions, such as SIO2, which have been in the portfolio for several years. He clarified that these are not new problems but ongoing operational workouts, with capital structures already restructured. The focus is on working with management teams to drive performance, sell assets, fund cash burn, or facilitate repayments, without any significant or monumental changes expected in the near term.
Ask follow-up questions
Fintool can predict
OCSL's earnings beat/miss a week before the call